Market revenue in 2024 | USD 164.9 million |
Market revenue in 2030 | USD 223.0 million |
Growth rate | 5.2% (CAGR from 2025 to 2030) |
Largest segment | Reagents product |
Fastest growing segment | Others Product |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments Product, Reagents Product, Others Product |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.74% in 2024. Horizon Databook has segmented the South Korea infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing awareness among people and rising government support are expected to drive growth of the infectious diseases molecular diagnostics market in South Korea. For instance, North Korea and South Korea have entered into an agreement to develop measures for combating infectious diseases, like TB.
In addition, increasing incidence of infectious diseases, such as scarlet fever, measles, mumps, hepatitis A, and pertussis, is expected to drive growth. Rise in geriatric population is also likely to significantly contribute to market growth in South Korea.
Growing geriatric population is also likely to aid market growth in South Korea. South Korea elderly population accounts for 15.6% of the residents. In addition, the country’s National Health Insurance program covers all residents.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account